Martin Steegmaier Person-Info 

( Ich bin Martin Steegmaier)

News

(1 - 4 von 17
)

SOTIO®

sotio.com
— SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced the appointment of Martin Steegmaier, Ph.D., MBA, ...

B3C newswire

www.biotechnewswire.ai
All Biotech News ; SOTIO Bolsters Leadership Team with Appointment of Martin Steegmaier as Chief Scientific Officer, ; ProBioGen Receives Employer of ...

Drug Discovery News

www.drugdiscoverynews.com
Martin Steegmaier, head of research at MorphoSys. “We believe that through dual targeting and highly specific activation of the cytotoxic T cells at the ...

GlobeNewswire

www.globenewswire.com
14, (GLOBE NEWSWIRE) -- SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced the appointment of Martin Steegmaier, Ph.
Dossier exportieren
+1